ClinicalTrials.gov
ClinicalTrials.gov Menu

Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin (MyoPac)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00691912
Recruitment Status : Terminated (Study was stopped due because recrutation.was much slower as anticipated.)
First Posted : June 6, 2008
Last Update Posted : September 3, 2014
Sponsor:
Information provided by (Responsible Party):
Claudia Lorenz-Schlüter, University of Magdeburg

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013